First Light Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-548
Closed -$319K 80
2020
Q4
$319K Hold
548
0.02% 60
2020
Q3
$282K Hold
548
0.03% 53
2020
Q2
$247K Buy
+548
New +$242K 0.03% 55
2020
Q1
Sell
-548
Closed -$203K 66
2019
Q4
$203K Buy
+548
New +$193K 0.03% 67
2016
Q4
Sell
-1,675
Closed -$274K 59
2016
Q3
$274K Hold
1,675
0.12% 63
2016
Q2
$240K Hold
1,675
0.11% 62
2016
Q1
$229K Hold
1,675
0.12% 65
2015
Q4
$232K Hold
1,675
0.1% 64
2015
Q3
$225K Hold
1,675
0.11% 62
2015
Q2
$252K Hold
1,675
0.12% 61
2015
Q1
$226K Hold
1,675
0.12% 61
2014
Q4
$202K Buy
+1,675
New +$193K 0.11% 66
2014
Q3
Sell
-1,675
Closed -$201K 63
2014
Q2
$201K Hold
1,675
0.14% 68
2014
Q1
$215K Hold
1,675
0.15% 70
2013
Q4
$207K Buy
+1,675
New +$204K 0.18% 66

Other funds holding BIO

First Light Asset Management's BIO Position: Q1 2021 in Review

First Light Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 548 shares — an estimated $319K sold.

First Light Asset Management first reported a position in BIO in Q4 2013 and held it in 15 quarters. The position peaked at $319K in Q4 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • First Light Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • First Light Asset Management sold 548 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $319K.
  • First Light Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2013 and held it in 15 quarters.
  • First Light Asset Management's Bio-Rad Laboratories Class A position peaked at $319K in Q4 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.